Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. (AVTE) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · AVTE · as of Jun 9, 2026
Activity summary
Buy transactions
1
P-Purchase only
Sell transactions
64
12 Months
Buy/Sell ratio
0.02
Buy/Sell (by trades)
Overall sentiment
Aerovate Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
AVTE insider buying and selling by quarter
AVTE insider selling · AVTE insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
AVTE executive sell shares · AVTE board member insider trading · AVTE insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 1, 2024 | Dake Benjamin T SEE REMARKS | Option | 1,507 | $3K | Form 4 |
| Jul 31, 2024 | Dake Benjamin T SEE REMARKS | Option | 11,454 | $20K | Form 4 |
| Jun 17, 2024 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | 928,110 | $1.55M⚡ | Form 4 |
| Jun 14, 2024 | Eldridge George A SEE REMARKS | Option | 15,000 | $32K | Form 4 |
| Jun 14, 2024 | Eldridge George A SEE REMARKS | Sale | 15,000 | $375K | Form 4 |
| Jun 14, 2024 | Verwijs Marinus CHIEF TECHNICAL OFFICER | Option | 10,600 | $155K | Form 4 |
| Jun 14, 2024 | Verwijs Marinus CHIEF TECHNICAL OFFICER | Sale | 10,600 | $265K | Form 4 |
| Jun 13, 2024 | Gillies Hunter CHIEF MEDICAL OFFICER | Option | 6,000 | $13K | Form 4 |
| Jun 13, 2024 | Gillies Hunter CHIEF MEDICAL OFFICER | Sale | 6,000 | $147K | Form 4 |
| May 17, 2024 | Gillies Hunter CHIEF MEDICAL OFFICER | Option | 4,000 | $9K | Form 4 |
| May 17, 2024 | Gillies Hunter CHIEF MEDICAL OFFICER | Sale | 3,914 | $82K | Form 4 |
| May 17, 2024 | Gillies Hunter CHIEF MEDICAL OFFICER | Sale | 86 | $2K | Form 4 |
| May 16, 2024 | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER · Director | Option | 10,000 | $21K | Form 4 |
| May 16, 2024 | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER · Director | Sale | 8,707 | $187K | Form 4 |
| May 16, 2024 | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER · Director | Sale | 1,293 | $28K | Form 4 |
| May 2, 2024 | Verwijs Marinus CHIEF TECHNICAL OFFICER | Sale | 1,981 | $42K | Form 4 |
| May 1, 2024 | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER · Director | Option | 10,000 | $21K | Form 4 |
| May 1, 2024 | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER · Director | Sale | 9,035 | $184K | Form 4 |
| May 1, 2024 | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER · Director | Sale | 1,357 | $27K | Form 4 |
| May 1, 2024 | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER · Director | Sale | 965 | $20K | Form 4 |
| Apr 17, 2024 | Dake Benjamin T SEE REMARKS | Option | 6,853 | $15K | Form 4 |
| Apr 17, 2024 | Dake Benjamin T SEE REMARKS | Sale | 6,447 | $144K | Form 4 |
| Apr 17, 2024 | Dake Benjamin T SEE REMARKS | Sale | 338 | $8K | Form 4 |
| Apr 17, 2024 | Dake Benjamin T SEE REMARKS | Sale | 68 | $2K | Form 4 |
| Apr 17, 2024 | Gillies Hunter CHIEF MEDICAL OFFICER | Option | 4,000 | $7K | Form 4 |
RA CAPITAL MANAGEMENT, L.P.
Director
Date
Jun 17
Shares
928,110
Price
$1.67
Value
$1.55M ⚡
Verwijs Marinus
CHIEF TECHNICAL OFFICER
Date
Jun 14
Shares
10,600
Price
$14.59
Value
$155K
Verwijs Marinus
CHIEF TECHNICAL OFFICER
Date
Jun 14
Shares
10,600
Price
$25.00
Value
$265K
Gillies Hunter
CHIEF MEDICAL OFFICER
Date
Jun 13
Shares
6,000
Price
$2.14
Value
$13K
Gillies Hunter
CHIEF MEDICAL OFFICER
Date
Jun 13
Shares
6,000
Price
$24.50
Value
$147K
Gillies Hunter
CHIEF MEDICAL OFFICER
Date
May 17
Shares
4,000
Price
$2.14
Value
$9K
Gillies Hunter
CHIEF MEDICAL OFFICER
Date
May 17
Shares
3,914
Price
$21.07
Value
$82K
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER · Director
Date
May 16
Shares
10,000
Price
$2.14
Value
$21K
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER · Director
Date
May 16
Shares
8,707
Price
$21.52
Value
$187K
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER · Director
Date
May 16
Shares
1,293
Price
$21.92
Value
$28K
Verwijs Marinus
CHIEF TECHNICAL OFFICER
Date
May 2
Shares
1,981
Price
$21.02
Value
$42K
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER · Director
Date
May 1
Shares
10,000
Price
$2.14
Value
$21K
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER · Director
Date
May 1
Shares
9,035
Price
$20.34
Value
$184K
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER · Director
Date
May 1
Shares
1,357
Price
$19.91
Value
$27K
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER · Director
Date
May 1
Shares
965
Price
$20.87
Value
$20K
Gillies Hunter
CHIEF MEDICAL OFFICER
Date
Apr 17
Shares
4,000
Price
$1.74
Value
$7K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About AVTE insider trading
AVTE insider trades
Aerovate Therapeutics, Inc. (AVTE) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including AVTE. Over the past 12 months, 0 insiders have filed transactions with the SEC. AVTE insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Aerovate Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
AVTE insider trading · 5 questionsThe insiders of Aerovate Therapeutics, Inc. (AVTE) include executives and directors such as AVTE, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026